BNP Paribas Financial Markets’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

BNP Paribas Financial Markets’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-812,820	Closed	-$720K	–	4134
2022 Q4	$720K	Sell	812,820 -109,647	-12%	-$145K	﹤0.01%	2362
2022 Q3	$1.45M	Buy	922,467 +833,596	+938%	+$1.89M	﹤0.01%	2208
2022 Q2	$179K	Buy	88,871 +63,976	+257%	+$111K	﹤0.01%	3140
2022 Q1	$58K	Sell	24,895 -39,198	-61%	-$122K	﹤0.01%	3526
2021 Q4	$298K	Buy	64,093 +13,817	+27%	+$85.8K	﹤0.01%	3248
2021 Q3	$384K	Buy	50,276 +40,171	+398%	+$341K	﹤0.01%	2850
2021 Q2	$97.9K	Sell	10,105 -22,121	-69%	-$176K	﹤0.01%	3050
2021 Q1	$267K	Buy	32,226 +3,714	+13%	+$39.2K	﹤0.01%	2905
2020 Q4	$195K	Sell	28,512 -94,136	-77%	-$756K	﹤0.01%	2893
2020 Q3	$1.37M	Sell	122,648 -149,210	-55%	-$1.37M	﹤0.01%	1666
2020 Q2	$1.71M	Buy	271,858 +229,252	+538%	+$878K	﹤0.01%	1575
2020 Q1	$78.4K	Buy	42,606 +24,717	+138%	+$71.2K	﹤0.01%	3330
2019 Q4	$60.5K	Sell	17,889 -401	-2%	-$956	﹤0.01%	3535
2019 Q3	$39.1K	Buy	18,290 +3,836	+27%	+$8.94K	﹤0.01%	3616
2019 Q2	$38.6K	Sell	14,454 -9,964	-41%	-$35.9K	﹤0.01%	3590
2019 Q1	$116K	Buy	+24,418	New	+$64.1K	﹤0.01%	3038
2018 Q4	–	Sell	-3,343	Closed	-$14.7K	–	4474
2018 Q3	$14.7K	Buy	3,343 +500	+18%	+$2.77K	﹤0.01%	3563
2018 Q2	$20.5K	Buy	+2,843	New	+$19.3K	﹤0.01%	3485
2017 Q2	–	Sell	-240	Closed	-$948	–	4368
2017 Q1	$948	Sell	240 -1,185	-83%	-$5.94K	﹤0.01%	3709
2016 Q4	$6.98K	Sell	1,425 -252	-15%	-$1.51K	﹤0.01%	3597
2016 Q3	$13K	Buy	1,677 +555	+49%	+$3.74K	﹤0.01%	3101
2016 Q2	$6.28K	Buy	+1,122	New	+$7.17K	﹤0.01%	3150
2016 Q1	–	Sell	-5,504	Closed	-$47.9K	–	3190
2015 Q4	$47.9K	Sell	5,504 -360	-6%	-$3.04K	﹤0.01%	2836
2015 Q3	$49.2K	Buy	5,864 +3,504	+148%	+$55.8K	﹤0.01%	2877
2015 Q2	$41.6K	Buy	+2,360	New	+$30.3K	﹤0.01%	2602